Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Observer Variation”

29 trials

Showing 20 of 29 results

Not applicableStudy completedNCT07416825
What this trial is testing

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

Who this might be right for
Esophageal CancerEsophageal Carcinoma
Institute of Oncology Ljubljana 23
Early research (Phase 1)Study completedNCT02325050
What this trial is testing

A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 164
Not applicableStudy completedNCT07413276
What this trial is testing

Prospective Evaluation of Clinical Endodontic Performance Assessment Methods

Who this might be right for
Root Canal Therapy
Aristotle University Of Thessaloniki 201
Not applicableStudy completedNCT02193646
What this trial is testing

Endoscopic Size Assessment of Advanced Adenomatous Polyps

Who this might be right for
Adenoma Detection Rate Improvement in Screening Colonoscopy
Rush University Medical Center 1,930
Large-scale testing (Phase 3)Study completedNCT05372588
What this trial is testing

Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines

Who this might be right for
COVID-19SARS CoV 2 Infection
Novavax 1,340
Not applicableStudy completedNCT00961948
What this trial is testing

Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Mayo Clinic 60
Not applicableStudy completedNCT01704066
What this trial is testing

Interobserver Variation in Applying a Radiographic Definition for Acute Respiratory Distress Syndrome (ARDS)

Who this might be right for
Acute Respiratory Distress Syndrome
Society of Critical Care Medicine, China 286
Large-scale testing (Phase 3)Study completedNCT05249829
What this trial is testing

Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 3,548
Early research (Phase 1)Study completedNCT05972993
What this trial is testing

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

Who this might be right for
COVID-19
GlaxoSmithKline 114
Not applicableStudy completedNCT02022319
What this trial is testing

The Observer Variation of Shear Wave Elastography

Who this might be right for
Thyroid Nodular Disease
University of Aarhus 72
Not applicableNot Yet RecruitingNCT07473869
What this trial is testing

Smartphone Application for Automated Measurement of Capillary Refill Time (CRT)

Who this might be right for
Capillary Refill TimePeripheral Tissue Perfusion
Assistance Publique - Hôpitaux de Paris 60
Testing effectiveness (Phase 2)Study completedNCT02416453
What this trial is testing

Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults

Who this might be right for
Ebola Viral Disease
Janssen Vaccines & Prevention B.V. 423
Large-scale testing (Phase 3)Study completedNCT04649151
What this trial is testing

Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 4,328
Post-approval studies (Phase 4)Active Not RecruitingNCT07266558
What this trial is testing

Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 30,000
Testing effectiveness (Phase 2)Study completedNCT02598388
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 578
Testing effectiveness (Phase 2)WithdrawnNCT05029856
What this trial is testing

Evaluation of the Safety and Immunogenicity of SII Vaccine Constructs Based on the SARS-CoV-2 (COVID-19) Variant in Adults

Who this might be right for
Covid19
Novavax
Not applicableStudy completedNCT02943018
What this trial is testing

Anovaginal Distance, Interobserver Agreement

Who this might be right for
Pelvic Floor Disorders
Ostergotland County Council, Sweden 40
Large-scale testing (Phase 3)UnknownNCT05580159
What this trial is testing

New Generation mRNA Booster Vaccine Against Emerging VOCs

Who this might be right for
ImmunogenicityEfficacySafety
Stemirna Therapeutics 2,000
Not applicableStudy completedNCT04911387
What this trial is testing

ICare® Home vs Goldmann Applanation Tonometry

Who this might be right for
GlaucomaOpen Angle GlaucomaOcular Hypertension+1 more
St. Erik Eye Hospital 61
Large-scale testing (Phase 3)Study completedNCT05517642
What this trial is testing

IH Convidecia as Second Booster Dose Against Breakthrough Infections

Who this might be right for
COVID-19
CanSino Biologics Inc. 540
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation